The review, conducted by Maryam Babar and Aymen Arain of the Edward Via College of Osteopathic Medicine and Nina Martins of Virginia Commonwealth University, synthesizes peer-reviewed literature identified through PubMed searches using terms such as cosmetic contamination, public testers, and pathogens in makeup. Rather than applying a formal systematic protocol, the authors took a narrative approach, examining studies of personal-use cosmetics, salon-shared products, preservative efficacy, and regulatory policy to build a comprehensive picture of what is, and is not, known about contamination in cosmetics that pass through many hands. Their central and most sobering finding is a gap in the evidence itself: no study to date has directly measured microbial loads or quantified infection risks from public makeup testers in retail settings.

What the surrounding literature does show is cause for concern. Studies of cosmetics in general use have repeatedly isolated opportunistic pathogens, including Staphylococcus aureus, Pseudomonas aeruginosa, Candida albicans, and various Bacillus species, from both personal and shared products. Alarmingly, contamination has been detected even in items that were still unopened, suggesting that manufacturing-stage contamination or compromised packaging can introduce microbes before a product ever reaches a consumer’s hands. Once products are in use, repeated contact with fingers, faces, and the environment introduces new organisms, and many formulations provide the water, nutrients, and neutral pH that microbial life requires.

The technical reasons why cosmetics can support microbial growth are well understood. Water-containing products such as creams, liquid foundations, and mascaras are particularly vulnerable, since moisture is the fundamental requirement for bacterial and fungal proliferation. Preservative systems are designed to suppress this growth, and regulatory frameworks in most jurisdictions require demonstrated preservative efficacy before a product can be marketed. However, preservatives are not infallible. Their effectiveness depends on concentration, formulation chemistry, and the size and frequency of the inoculum they face. A tester that is opened all day, handled by dozens or hundreds of people, and never sanitized may present a microbial challenge that overwhelms even a well-designed preservative system. Research on preservative systems has also shown that they can alter the skin microbiome itself, complicating the picture of how cosmetic formulations interact with the microorganisms that naturally colonize healthy skin.

The closest real-world proxy for retail testers comes from studies of communal cosmetic kits in beauty salons, and those findings are consistently troubling. Investigations of shared makeup kits in women’s beauty salons have documented high rates of bacterial and fungal contamination, with contamination levels notably higher in communal-use settings than in products used by a single owner. One study of salon cosmetics also assessed exposure to microbial metabolites, underscoring that the risks of shared products may extend beyond live organisms to the bioactive compounds they produce. In a salon, the shared kit is typically used by a limited and semi-stable population; a retail tester, by contrast, may be touched by an essentially unbounded stream of strangers, none of whom have any knowledge of the product’s handling history.

The clinical consequences of exposure to contaminated cosmetics range from trivial to serious. Opportunistic pathogens such as Pseudomonas aeruginosa can cause severe eye infections, including keratitis that threatens vision, particularly when contaminated products contact the eye area around mascaras, eyeliners, and eye shadow. Staphylococcus aureus can provoke skin and soft tissue infections and, in some cases, more invasive disease. Candida albicans poses particular risks to immunocompromised individuals. Perhaps most strikingly, a recent study found that makeup testers can act as reservoirs and transmission sources of antibiotic-resistant bacteria, meaning that a swipe of contaminated lip gloss could theoretically transfer organisms that are difficult to treat even when they do cause infection. For vulnerable users, including people with compromised immune systems, broken skin, chronic skin conditions, or recent cosmetic procedures, exposure to contaminated testers represents a heightened and largely unrecognized risk.

Despite this accumulating evidence of risk in adjacent settings, the review emphasizes that retail testers themselves exist in a regulatory vacuum. There are no mandated sanitation protocols for testers, no requirements to track how long a tester has been in use, no expiration tracking for opened demonstration products, and no microbial testing obligations. In contrast, finished cosmetics sold to consumers are subject to established safety and shelf-life regulations in Europe and internationally, including requirements for preservative efficacy and period-after-opening labeling. A tester on a store counter, which may be exposed to more microbial pressure than any personal product ever will be, is exempt from all of these protections. The authors argue that this asymmetry is difficult to justify from a public health standpoint and that testers may serve as unrecognized vectors for microbial transmission and infection.

The methodological gap the review identifies is as important as the contamination findings themselves. Because no studies have directly sampled testers in real retail environments, the actual magnitude of the risk remains unknown. Microbial loads on testers could range from negligible to dangerous, and without direct measurement, neither regulators nor retailers can make evidence-based decisions. The authors call for research to evaluate the safety of these products in real-world settings, including surveys of contamination across product types, store formats, and climates, as well as studies quantifying the transfer of microbes from tester to skin. Such data would provide the foundation for establishing evidence-based hygiene protocols, whether that means scheduled sanitization, single-use applicators, sealed sampling systems, automatic replacement intervals, or the retirement of open testers altogether.

In the meantime, the review has practical implications for consumers and retailers alike. Shoppers with cuts, active skin infections, recent procedures, or weakened immune systems would be prudent to avoid shared testers entirely, particularly around the eye and lip areas where the infection risk is highest. Retailers and cosmetics companies, for their part, could adopt sanitation and replacement practices voluntarily, and the authors argue that recognizing the clinical relevance of tester contamination is essential for guiding future policy, public health measures, and consumer education in cosmetic safety. As the beauty industry continues to grow and as awareness of microbiome science reshapes how consumers think about the products they put on their skin, the humble makeup tester, sitting open on a brightly lit counter, may come to be seen less as a harmless indulgence and more as an unexamined interface between hundreds of strangers’ microbiomes and every new customer who stops to try a shade.

It is worth noting the nature of the evidence base itself. As a narrative review, the article does not pool data or grade studies systematically, and the authors acknowledge that no formal inclusion or exclusion criteria were applied. This means the conclusions should be read as a synthesis of available literature rather than a quantitative risk assessment, which makes their call for direct sampling studies all the more pointed. The review also received no external funding, and the authors declared no conflicts of interest.

The cited literature adds several instructive details. Quality investigations of commonly used topical cosmetic preparations have documented contamination in products beyond makeup, suggesting the problem spans cosmetic categories. Work on preservative systems in full formulations has examined their in-vivo effects on the skin microbiome, while separate research has tested how chemical preservatives affect resident flora isolated from healthy facial skin, indicating that formulation choices shape not only microbial survival in the product but also the ecology of the skin it contacts. Even unusual organisms have surfaced: Vibrio metschnikovii has been isolated from cosmetic products and proposed as a potential cause of skin infection, illustrating that the range of contaminants is not limited to the familiar staphylococcal and pseudomonal species.

The timeline of the underlying research is also relevant. Much of the foundational work on in-use cosmetic contamination dates back well over a decade, while studies of salon-shared kits and antibiotic-resistant organisms on testers are more recent, suggesting growing but still fragmented attention to the issue. The review went through revision in August 2026 and was published in September 2026 in volume 318 of the journal, arriving at a moment when consumer interest in microbiome-aware cosmetics is rising even as the hygiene of the products consumers actually touch in stores remains unmeasured.

Subject of Research: Microbial contamination of shared makeup testers in retail environments and its public health implications.

Article Title: Beauty or biohazard? Microbial contamination in shared makeup testers and public health implications: a narrative review

Article References: Babar, M., Arain, A., & Martins, N. (2026). Beauty or biohazard? Microbial contamination in shared makeup testers and public health implications: a narrative review. Archives of Dermatological Research, 318(1), Article 404. https://doi.org/10.1007/s00403-026-04928-6

Image Credits: AI Generated

DOI: 10.1007/s00403-026-04928-6

Keywords: cosmetic contamination, makeup testers, microbial safety, opportunistic pathogens, public health, skin microbiome, hygiene practices, antibiotic-resistant bacteria, beauty salons, preservative efficacy, Staphylococcus aureus, Pseudomonas aeruginosa

The human skin, often viewed merely as a physical barrier, actually represents a complex and dynamic ecosystem housing millions of microorganisms including bacteria, fungi, and viruses. Each anatomical site on the skin hosts a unique microbiome composition that delicately interacts with host cells and immune pathways. These commensal microbes are not passive occupants; they adaptively metabolize various substrates present in the skin microenvironment, producing metabolites that influence both their own survival and host physiology. This intricate interplay has been recognized increasingly as central to maintaining skin homeostasis and responding to external stresses.

Investigators led by Dr. VijayKumar Patra, affiliated with the Centre International de Recherche en Infectiologie in Lyon and the Medical University of Graz’s Research Unit for Photodermatology, embarked on an in-depth exploration of how these microbial communities respond to UVB radiation—the primary culprit behind sunburn and an initiator of profound immune modulation in the skin. Their curiosity stemmed from the hypothesis that microbes might actively participate in or even modify the biological effects instigated by UV exposure, blurring the lines between microbial metabolism and host immune function.

Utilizing cutting-edge microbiome sequencing combined with detailed immunological assays, the research team employed in vitro bacterial cultures alongside sophisticated gnotobiotic mouse models where microbial populations are precisely defined. This approach allowed for a controlled dissection of microbial responses to UVB radiation. Their investigations pinpointed a subset of skin bacteria expressing an enzyme known as urocanase. This enzyme catalyzes the conversion of cis-urocanic acid, a molecule formed during UV exposure from its precursor trans-urocanic acid, thereby altering its well-established immunosuppressive signaling within the skin.

cis-urocanic acid has long been understood as a potent modulator of cutaneous immune responses, typically dampening the immune system’s activity following UV exposure to prevent overactivation and tissue damage. However, this immunosuppressive effect can inadvertently contribute to increased skin cancer risk by attenuating immune surveillance. The discovery that bacterial urocanase metabolizes cis-urocanic acid effectively reduces its immune-inhibitory properties, suggesting that microbial communities exert a balancing influence on UV-induced immunosuppression and may protect against detrimental immune outcomes.

The study further delves into the nuanced competition occurring at the stratum corneum, the skin’s outermost layer, where sunscreens, cis-urocanic acid, and skin microbiota coexist and interact. This triad paradoxically influences one another: while sunscreens block UV radiation to protect host skin cells, they may also indirectly affect microbial metabolism and the dynamics of immunomodulatory metabolites like cis-urocanic acid. Such insights raise important considerations regarding how topical photoprotection strategies might be refined to preserve or even harness beneficial microbial functions.

Dr. Marc Vocanson, co-investigator at the Centre International de Recherche en Infectiologie, highlights the research’s pioneering nature by stating, “This is the first demonstration of a direct metabolic link between a host UV-induced molecule and bacterial enzymatic activity influencing immune functions. As the fields of microbiome science and personalized medicine expand, understanding these interactions could revolutionize approaches to sun protection, immune-related dermatological diseases, and phototherapy protocols.”

Similarly, Dr. Peter Wolf from the Medical University of Graz emphasizes the translational potential of these findings, projecting a future where sun protection transcends mere UV blocking to become microbiome-aware. Topical treatments might be engineered to modulate microbial metabolism, strategically maintaining or adjusting UV-induced immunosuppression for therapeutic advantage, particularly in managing conditions amenable to phototherapy or immunomodulation.

The implications stretch beyond the immediate skin immunology realm. This work challenges traditional concepts of the skin barrier by reconceptualizing it as a metabolically active and microbially regulated interface rather than a mere passive shield. Dr. Anna Di Nardo, a distinguished expert from the University of California San Diego and the San Gallicano Dermatological Institute IRCCS in Rome, recognizes this paradigm shift: “The skin microbiome is not a silent bystander to environmental insults like UV radiation, but a dynamic participant modulating immune tolerance through metabolic activities such as the degradation of cis-urocanic acid. These insights open exciting avenues for novel therapeutic and preventive strategies targeting skin aging, UV-induced carcinogenesis, and immune dysregulation.”

Mechanistically, the bacterial urocanase enzyme acts by converting cis-urocanic acid into metabolites that are less immune-inhibitory, effectively diminishing the molecule’s capacity to attenuate antigen-presenting cell activation, T-cell responses, and overall immune balance within the skin microenvironment. This critical metabolic step underscores a hitherto unappreciated microbial contribution to preserving immune vigilance despite repeated UV insults, which historically was thought to be predominantly host-driven.

The study’s methodology exemplifies modern interdisciplinary approaches in dermatological research, integrating microbiology, immunology, photobiology, and molecular enzymology. Gnotobiotic mouse models, wherein microbial populations are precisely manipulated, offer unparalleled insights into how defined bacteria influence host immune modulation. Such experimental rigor ensures the causative role of urocanase-expressing bacteria, ruling out confounding variables and establishing a clear causal link between microbial metabolism and skin immune responses.

In conclusion, the revelation that skin-resident bacteria metabolize cis-urocanic acid to modulate UV-induced immunosuppressive effects not only deepens our understanding of skin biology but also compels the dermatological and microbiome research communities to rethink therapeutic strategies. This newfound knowledge situates the skin microbiome as an active mediator capable of influencing immune outcomes and suggests innovative directions for developing microbiome-targeted interventions to improve skin health and combat diseases associated with UV exposure.

Moving forward, this research sets a robust foundation for exploring microbiome-based diagnostics and treatments that could harmonize host-microbial interactions to optimize photoprotection, reduce skin cancer risks, and enhance immunomodulatory therapies. As interest intensifies in the role of microbes as key players within human physiology, the skin emerges as an accessible and complex model system where microbial metabolism and host immunity intersect with profound clinical implications.

Subject of Research: Cells

Article Title: Urocanase-Positive Skin Resident Bacteria Metabolize cis-Urocanic Acid and in Turn Reduce the Immunosuppressive Properties of UV Radiation

News Publication Date: 13-May-2025

Web References:
https://doi.org/10.1016/j.jid.2025.03.035

References:
Published in Journal of Investigative Dermatology, May 13, 2025

Keywords: Skin microbiome, urocanase, cis-urocanic acid, ultraviolet radiation, immunosuppression, photoprotection, microbial metabolism, host-microbiome interaction, skin immunity, phototherapy, UVB radiation, enzymatic metabolism